|
LM_ID
|
Common Name
|
Systematic Name
|
Main class
|
Sub class
|
Mass
|
Formula
|
|
LMFA01030748
|
5,6,15-trihydroxy-7,9,13-Eicosatrien-11-ynoic acid
|
5,6,15-trihydroxy-7,9,13-Eicosatrien-11-ynoic acid
|
Fatty Acids and Conjugates [FA01]
|
Unsaturated fatty acids [FA0103]
|
350.21
|
C20H30O5
|
|
LMFA03010205
|
15-dehydro-prostaglandin I2
|
6,9S-epoxy-11R-hydroxy-15-oxo-5Z,13E-prostadienoic acid
|
Eicosanoids [FA03]
|
Prostaglandins [FA0301]
|
350.21
|
C20H30O5
|
|
LMFA03010206
|
15-keto-PGD2
|
9S-hydroxy-11,15-dioxo-5Z,13E-prostadienoic acid
|
Eicosanoids [FA03]
|
Prostaglandins [FA0301]
|
350.21
|
C20H30O5
|
|
LMFA03010030
|
15-keto-PGE2
|
9,15-dioxo-11R-hydroxy-5Z,13E-prostadienoic acid
|
Eicosanoids [FA03]
|
Prostaglandins [FA0301]
|
350.21
|
C20H30O5
|
|
LMFA03010130
|
19-hydroxy-PGA2
|
9oxo-15S,19-dihydroxy-5Z,10Z,13E-prostatrienoic acid
|
Eicosanoids [FA03]
|
Prostaglandins [FA0301]
|
350.21
|
C20H30O5
|
|
LMFA03010132
|
19-hydroxy-PGB2
|
9-oxo-15S,19-dihydroxy-5Z,8(12),13E-prostatrienoic acid
|
Eicosanoids [FA03]
|
Prostaglandins [FA0301]
|
350.21
|
C20H30O5
|
|
LMFA03010166
|
19R-hydroxy-PGA2
|
9-oxo-15S,19R-dihydroxy-5Z,10Z,13E-prostatrienoic acid
|
Eicosanoids [FA03]
|
Prostaglandins [FA0301]
|
350.21
|
C20H30O5
|
|
LMFA03010167
|
19R-hydroxy-PGB2
|
9-oxo-15S,19R-dihydroxy-5Z,8(12),13E-prostatrienoic acid
|
Eicosanoids [FA03]
|
Prostaglandins [FA0301]
|
350.21
|
C20H30O5
|
|
LMFA03010142
|
PGD3
|
9S,15S-dihydroxy-11-oxo-5Z,13E,17Z-prostatrienoic acid
|
Eicosanoids [FA03]
|
Prostaglandins [FA0301]
|
350.21
|
C20H30O5
|
|
LMFA03010135
|
PGE3
|
9-oxo-11R,15S-dihydroxy-5Z,13E,17Z-prostatrienoic acid
|
Eicosanoids [FA03]
|
Prostaglandins [FA0301]
|
350.21
|
C20H30O5
|
|
LMFA03010045
|
PGI3
|
6,9S-epoxy-11R,15S-dihydroxy-15Z,13E,17Z-prostatrienoic acid
|
Eicosanoids [FA03]
|
Prostaglandins [FA0301]
|
350.21
|
C20H30O5
|
|
LMFA03010023
|
PGK2
|
9,11-dioxo-15S-hydroxy-5Z,13E-prostadienoic acid
|
Eicosanoids [FA03]
|
Prostaglandins [FA0301]
|
350.21
|
C20H30O5
|
|
LMFA03020049
|
12-Oxo-20-hydroxy-leukotriene B4
|
(5R,6Z,8E,10E,14Z)-5,20-dihydroxy-12-oxoicosa-6,8,10,14-tetraenoic acid
|
Eicosanoids [FA03]
|
Leukotrienes [FA0302]
|
350.21
|
C20H30O5
|
|
LMFA03020053
|
15-Epi-lipoxin B5
|
(5R,6E,8Z,10E,12E,14R,15R,17Z)-5,14,15-trihydroxyicosa-6,8,10,12,17-pentaenoic acid
|
Eicosanoids [FA03]
|
Leukotrienes [FA0302]
|
350.21
|
C20H30O5
|
|
LMFA03020064
|
20-oxo-leukotriene B4
|
(5S,6Z,8E,10E,12R,14Z)-5,12-dihydroxy-20-oxoicosa-6,8,10,14-tetraenoic acid
|
Eicosanoids [FA03]
|
Leukotrienes [FA0302]
|
350.21
|
C20H30O5
|
|
LMFA03030005
|
TXA3
|
9S,11S-epoxy,15S-hydroxy-thromboxa-5Z,13E,17Z-trien-1-oic acid
|
Eicosanoids [FA03]
|
Thromboxanes [FA0303]
|
350.21
|
C20H30O5
|
|
LMFA03040011
|
15-Oxo-lipoxin A4
|
(5R,6R,7E,9E,11Z,13E)-5,6-dihydroxy-15-oxoicosa-7,9,11,13-tetraenoic acid
|
Eicosanoids [FA03]
|
Lipoxins [FA0304]
|
350.21
|
C20H30O5
|
|
LMFA03040009
|
15-oxo-LXA4
|
15-oxo-5S,6R-dihydroxy-7E,9E,11Z,13E-eicosatetraenoic acid
|
Eicosanoids [FA03]
|
Lipoxins [FA0304]
|
350.21
|
C20H30O5
|
|
LMFA03040012
|
Lipoxin A5
|
5S,6R,15S-trihydroxy-7E,9E,11Z,13E-eicosatetraenoic acid
|
Eicosanoids [FA03]
|
Lipoxins [FA0304]
|
350.21
|
C20H30O5
|
|
LMFA03070042
|
5,6,18-triHEPE
|
5,6,18-trihydroxy-7E,9E,11E,14Z,16Z-eicosapentaenoic acid
|
Eicosanoids [FA03]
|
Hydroxy/hydroperoxyeicosapentaenoic acids [FA0307]
|
350.21
|
C20H30O5
|
|
LMFA03070034
|
5S-Hp-18R-HEPE
|
5S-hydroperoxy-18R-hydroxy-6E,8Z,11Z,14Z,16E-eicosapentaenoic acid
|
Eicosanoids [FA03]
|
Hydroxy/hydroperoxyeicosapentaenoic acids [FA0307]
|
350.21
|
C20H30O5
|
|
LMFA03070039
|
5S-Hp-18S-HEPE
|
5S-hydroperoxy-18S-hydroxy-6E,8Z,11Z,14Z,16E-eicosapentaenoic acid
|
Eicosanoids [FA03]
|
Hydroxy/hydroperoxyeicosapentaenoic acids [FA0307]
|
350.21
|
C20H30O5
|
|
LMFA03070041
|
6-trans-5,12,18-triHEPE
|
5,12,18-trihydroxy-6E,8E,10E,14Z,16Z-eicosapentaenoic acid
|
Eicosanoids [FA03]
|
Hydroxy/hydroperoxyeicosapentaenoic acids [FA0307]
|
350.21
|
C20H30O5
|
|
LMFA03110009
|
8-iso-15-keto-PGE2
|
9,15-dioxo-11R-hydroxy-5Z,13E-prostadienoic acid-cyclo[8S,12R]
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
350.21
|
C20H30O5
|
|
LMFA03140002
|
10,11-dihydro-12-oxo-Resolvin E1
|
12-oxo-5S,18S-dihydroxy-6Z,8E,14Z,16E-eicosatetraenoic acid
|
Eicosanoids [FA03]
|
Resolvin Es [FA0314]
|
350.21
|
C20H30O5
|
|
LMFA03140009
|
18S-Resolvin E1
|
5S,12R,18S-trihydroxy-6Z,8E,10E,14Z,16E-eicosapentaenoic acid
|
Eicosanoids [FA03]
|
Resolvin Es [FA0314]
|
350.21
|
C20H30O5
|
|
LMFA03140003
|
Resolvin E1
|
5S,12R,18R-trihydroxy-6Z,8E,10E,14Z,16E-eicosapentaenoic acid
|
Eicosanoids [FA03]
|
Resolvin Es [FA0314]
|
350.21
|
C20H30O5
|